Open AccessNew perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
Author(s) -
Matsuzaka Takashi,
Shimano Hitoshi
Publication year - 2020
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13258
Subject(s) - dyslipidemia , medicine , diabetes mellitus , endocrinology , type 2 diabetes , cholesterol , triglyceride , type 2 diabetes mellitus , lipid profile , high density lipoprotein , disease , lipoprotein
Serum lipid abnormalities (dyslipidemias) are major risk factors for cardiovascular disease in type 2 diabetes mellitus. Recent findings provide new evidence that dyslipidemia characterized by elevated triglycerides and non‐high‐density lipoprotein cholesterol levels with a decreased high‐density lipoprotein cholesterol level are risk factors for cardiovascular disease in patients with type 2 diabetes. There are multiple therapeutic agents to help patients to achieve target lipid levels, but understanding the molecular mechanisms could provide useful information for new treatment strategies for diabetic dyslipidemia.